ConductScience.org, home

Paper359018

Acebutolol in hypertension--double-blind trial against placebo.

Martin MA and 2 others. Br J Clin Pharmacol, 1978. Cited by 28 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Acebutolol in hypertension--double-blind trial against placebo. Papers, record 359018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/359018

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Acebutolol in hypertension--double-blind trial against placebo.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
1.97
iCite
Revised in PubMed
2019-05-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Martin MAM A
2Phillips CAC A
3Smith AJA J

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcebutololMajor topic
HypertensionMajor topic
Adult
Aged
Blood Pressure
Clinical Trials as Topic
Double-Blind Method
Echocardiography
Female
Humans
Male
Middle Aged
Placebos
Pulse

Source PubMed

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,503Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker).Am J Med1976https://conductscience.org/library/papers/14503PubMed
214,502Beta-adrenoreceptor blockade in hypertension.Am J Med1976https://conductscience.org/library/papers/14502PubMed
3329,948Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension.Br Med J1977https://conductscience.org/library/papers/329948PubMed
4788,758The effect on blood pressure of beta-adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased.Br J Clin Pharmacol1976https://conductscience.org/library/papers/788758PubMed
51,071,666Anti-hypertensive effect of acebutolol: its relation to sympathetic nervous system responsiveness and to plasma renin and dopamine-beta-hydroxylase activities.Clin Sci Mol Med Suppl1976https://conductscience.org/library/papers/1071666PubMed
61,052,165Control of hypertension with single daily doses of sotalol hydrochloride.Curr Med Res Opin1976https://conductscience.org/library/papers/1052165PubMed
71,001,000An open, multicentre study of acebutolol in hypertension.Curr Med Res Opin1976https://conductscience.org/library/papers/1001000PubMed
81,233,201Properties of acebutolol in twenty patients with cardiac arrhythmias.Eur J Clin Pharmacol1975https://conductscience.org/library/papers/1233201PubMed
953,978Studies of the hypothalamus and the pituitary gland with special reference to the effects of transection of the pituitary stalk.Acta Endocrinol Suppl (Copenh)1975https://conductscience.org/library/papers/53978PubMed
104,147,427Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A.Br J Pharmacol1973https://conductscience.org/library/papers/4147427PubMed
114,150,000Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.Circulation1973https://conductscience.org/library/papers/4150000PubMed
124,146,876Sectral in the management of angina pectoris.S Afr Med J1973https://conductscience.org/library/papers/4146876PubMed
134,149,613Beta-blockers and plasma renin activity in hypertension.Br Med J1974https://conductscience.org/library/papers/4149613PubMed
144,327,019Accurate and rapid measurement of plasma renin activity by radioimmunoassay. Results in normal and hypertensive people.J Lab Clin Med1971https://conductscience.org/library/papers/4327019PubMed
1547,018Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity?Lancet1975https://conductscience.org/library/papers/47018PubMed
167,342Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment.Br Med J1976https://conductscience.org/library/papers/7342PubMed
176,245Haemodynamic effects of beta-adrenorecptor blockers in hypertension.Drugs1976https://conductscience.org/library/papers/6245PubMed
184,693,098Factors influencing the urinary excretion of free catecholamines in man.Clin Sci1973https://conductscience.org/library/papers/4693098PubMed
195,084,985Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.N Engl J Med1972https://conductscience.org/library/papers/5084985PubMed
20772,425Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone.N Engl J Med1976https://conductscience.org/library/papers/772425PubMed

See all 26 references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
7,059,418Antihypertensive action of acebutolol (Sectral) when used concomitantly with hydrochlorothiazide.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7059418PubMed
6,969,082Antinuclear antibodies and acebutolol.Br J Clin Pharmacol1980https://conductscience.org/library/papers/6969082PubMed
6,766,731Comparison of once and twice daily administration of acebutolol in hypertension.Br J Clin Pharmacol1980https://conductscience.org/library/papers/6766731PubMed
6,626,416Acebutolol pharmacokinetics in renal failure.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6626416PubMed
3,891,306Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.Drugs1985https://conductscience.org/library/papers/3891306PubMed
367,793Acebutolol in hypertension: relationships between drug concentration and effects.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/367793PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5,972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/359018

GET https://conductscience.org/api/papers/v1/359018/references?page=2